Desk› Healthcare› ANG Lifesciences India Ltd
ANG Lifesciences India Ltd
Filing rhythm · 60 trading days
6 filings · 2 material · busiest 2026-08-14
What it files
Filings
6 in the window
-
14 August 2026
Board OutcomeBoard Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015
Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations, 2015
Board Meeting / Outcome of Board Meeting View filing →
-
14 August 2026
ResultsSubmission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015
Financial Results 30.06.2026.
Result / Financial Results View filing →
-
7 August 2026
Board MeetingBoard Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026.
ANG Lifesciences India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....
Board Meeting / Board Meeting View filing →
-
21 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Reg 74(5) Certificate
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
19 June 2026
Trading WindowClosure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
5 June 2026
Newspaper PublicationNewspaper Publication
Newspaper Publication of Audited Financial Results for the quarter and year ended March 31, 2026.
Company Update / Newspaper Publication View filing →